Central Nervous System News and Research

RSS

Researchers find roving detection system for treating cancer, Parkinson's disease and ALS

Duke University researchers have found a "roving detection system" on the surface of cells that may point to new ways of treating diseases like cancer, Parkinson's disease and amyotrophic lateral sclerosis (ALS).

26 Aug 2014

NeuroDerm signs definitive investment agreements for $16 million financing round

NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group.

21 Aug 2014

Research validates Myc inhibition as effective therapeutic strategy for glioma

Research led by the Vall d'Hebron Institute of Oncology (VHIO) evidence the most conclusive preclinical results to-date validating Myc inhibition as a therapeutic strategy in glioma - a highly agressive tumor type that notoriously outsmarts current anti-cancer therapies.

19 Aug 2014

FDA approves BELSOMRA® (suvorexant) for the treatment of insomnia

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved BELSOMRA® (suvorexant) for adults with insomnia who have difficulty falling asleep and/or staying asleep. BELSOMRA (pronounced bell-SOM-rah) is a highly selective antagonist for orexin receptors.

15 Aug 2014

Prevalence of bacterial meningitis drops in the United States

Advances in the prevention and treatment of an often fatal condition called bacterial meningitis appear to be paying dividends in the United States, report infectious disease experts at The University of Texas Health Science Center at Houston (UTHealth) in the journal The Lancet Infectious Diseases.

13 Aug 2014

Imaging system rapidly detects molecular marker in brain gliomas, enables removal of tumor

During tumor surgery, surgeons work to remove tumor tissue without damaging surrounding healthy tissue.

13 Aug 2014

Huntingtin protein plays critical role in long-term memory development

It has been more than 20 years since scientists discovered that mutations in the gene huntingtin cause the devastating progressive neurological condition Huntington's disease, which involves involuntary movements, emotional disturbance and cognitive impairment.

13 Aug 2014

Study: Brain tumors hijack the brain's existing blood supply during progression

Dangerous brain tumors hijack the brain's existing blood supply throughout their progression, by growing only within narrow potential spaces between and along the brain's thousands of small blood vessels, new research shows for the first time.

12 Aug 2014

Study provides new insight into neuroprotective effects of Asiaticoside

In the central nervous system, Asiaticoside has been shown to attenuate in vitro neuronal damage caused by exposure to β-amyloid.

12 Aug 2014

Omeros reports net loss of $18 million for second quarter 2014

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced financial results and highlights for the second quarter of 2014.

12 Aug 2014

Neurons derived from human iPSC and grafted into rats after spinal cord injury produce cells

Building upon previous research, scientists at the University of California, San Diego School of Medicine and Veteran's Affairs San Diego Healthcare System report that neurons derived from human induced pluripotent stem cells (iPSC) and grafted into rats after a spinal cord injury produced cells with tens of thousands of axons extending virtually the entire length of the animals' central nervous system.

8 Aug 2014

Dimethyl fumarate offers no added benefits for adults with RRMS

Dimethyl fumarate has been approved since January 2014 for adults with relapsing remitting multiple sclerosis.

8 Aug 2014

Higher caffeine intake associated with lower rates of tinnitus

New research from Brigham and Women's Hospital (BWH) finds that higher caffeine intake is associated with lower rates of tinnitus, often described as a ringing or buzzing sound in the ear when there is no outside source of the sounds, in younger and middle-aged women.

7 Aug 2014

Researcher highlights potential for interaction between key CNS plasticity mechanisms

The adult CNS is remarkably adaptable - it retains the ability to generate and integrate new cells, and remodel pre-existing circuits.

7 Aug 2014

Induced immunorejection may eliminate tumors post-cell transplantation

Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation.

7 Aug 2014

Children with fetal alcohol spectrum disorders show weaker brain activation

In the first study of its kind, Prapti Gautam, PhD, and colleagues from The Saban Research Institute of Children's Hospital Los Angeles found that children with fetal alcohol spectrum disorders (FASD) showed weaker brain activation during specific cognitive tasks than their unaffected counterparts.

5 Aug 2014

New IOM report includes recommendations to overhaul current graduate medical education system

The Institute of Medicine released a report, Graduate Medical Education That Meets the Nation's Health Needs, which encompasses recommendations to overhaul the current graduate medical education (GME) system.

31 Jul 2014

Researchers investigate functional performance in children with spina bifida

Spina bifda (SB) is a complex congenital central nervous system disease that is caused by the incomplete closing of the neural tubes during the embryonic phase.

26 Jul 2014

Scientists one step closer to creating viable cell replacement therapy for multiple sclerosis patients

Scientists at The New York Stem Cell Foundation Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.

25 Jul 2014

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Shire plc, the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy (ERT) for the potential treatment of both the central nervous system (CNS) and somatic manifestations in patients with Hunter syndrome (MPS II).

23 Jul 2014

Central Nervous System News and Research

Researchers find roving detection system for treating cancer, Parkinson's disease and ALS

NeuroDerm signs definitive investment agreements for $16 million financing round

Research validates Myc inhibition as effective therapeutic strategy for glioma

FDA approves BELSOMRA® (suvorexant) for the treatment of insomnia

Prevalence of bacterial meningitis drops in the United States

Imaging system rapidly detects molecular marker in brain gliomas, enables removal of tumor

Huntingtin protein plays critical role in long-term memory development

Study: Brain tumors hijack the brain's existing blood supply during progression

Study provides new insight into neuroprotective effects of Asiaticoside

Omeros reports net loss of $18 million for second quarter 2014

Neurons derived from human iPSC and grafted into rats after spinal cord injury produce cells

Dimethyl fumarate offers no added benefits for adults with RRMS

Higher caffeine intake associated with lower rates of tinnitus

Researcher highlights potential for interaction between key CNS plasticity mechanisms

Induced immunorejection may eliminate tumors post-cell transplantation

Children with fetal alcohol spectrum disorders show weaker brain activation

New IOM report includes recommendations to overhaul current graduate medical education system

Researchers investigate functional performance in children with spina bifida

Scientists one step closer to creating viable cell replacement therapy for multiple sclerosis patients

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Event guide: The 7th CNS Drug Delivery Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News